164 related articles for article (PubMed ID: 31661906)
1. Praziquantel-Solid Lipid Nanoparticles Produced by Supercritical Carbon Dioxide Extraction: Physicochemical Characterization, Release Profile, and Cytotoxicity.
Andrade LN; Oliveira DML; Chaud MV; Alves TFR; Nery M; da Silva CF; Gonsalves JKC; Nunes RS; Corrêa CB; Amaral RG; Sanchez-Lopez E; Souto EB; Severino P
Molecules; 2019 Oct; 24(21):. PubMed ID: 31661906
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
Xie S; Pan B; Wang M; Zhu L; Wang F; Dong Z; Wang X; Zhou W
Nanomedicine (Lond); 2010 Jul; 5(5):693-701. PubMed ID: 20662641
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured Lipid Carriers as a Strategy to Improve the In Vitro Schistosomiasis Activity of Praziquantel.
Kolenyak-Santos F; Garnero C; de Oliveira RN; de Souza AL; Chorilli M; Allegretti SM; Longhi MR; Chaud MV; Gremião MP
J Nanosci Nanotechnol; 2015 Jan; 15(1):761-72. PubMed ID: 26328440
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against
Adekiya TA; Kumar P; Kondiah PPD; Ubanako P; Choonara YE
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012770
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm.
Xie S; Pan B; Shi B; Zhang Z; Zhang X; Wang M; Zhou W
Int J Nanomedicine; 2011; 6():2367-74. PubMed ID: 22072873
[TBL] [Abstract][Full Text] [Related]
8. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
[TBL] [Abstract][Full Text] [Related]
9. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
10. Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.
Rahiminejad A; Dinarvand R; Johari B; Nodooshan SJ; Rashti A; Rismani E; Mahdaviani P; Saltanatpour Z; Rahiminejad S; Raigani M; Khosravani M
Cell Biol Int; 2019 Jan; 43(1):2-11. PubMed ID: 30080277
[TBL] [Abstract][Full Text] [Related]
11. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
13. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
14. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
15. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
16. Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro.
Li N; Li X; Cheng P; Yang P; Shi P; Kong L; Liu H
Evid Based Complement Alternat Med; 2021; 2021():4828169. PubMed ID: 34745284
[TBL] [Abstract][Full Text] [Related]
17. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release].
Chen YJ; Jin RX; Zhou YQ; Zeng J; Zhang H; Feng QR
Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):376-9. PubMed ID: 16711418
[TBL] [Abstract][Full Text] [Related]
20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]